Home
Latest
E-paper
Companies
Industry
Economy
Finance
Markets
Budget 2025
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Video Gallery
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Ind-Swift Labs to sell pharma ingredients ops to Synthimed Labs for $198 mn
Ind-Swift Labs will sell its active pharmaceuticals ingredients (API) and contract research and manufacturing services (CRAMS) business
PI Industries plunges 8% on termination of Ind-Swift slump sale agreement
The agreement had to be cancelled due to non-completion of several pre-agreed conditions precedents by Ind-Swift Labs
Ind-Swift Lab zooms 83% in seven trading days on debt settlement hope
The stock is trading at its 52-week high of Rs 67.30, zooming 83% in past seven trading sessions from Rs 36.80 on December 14, 2017.
